This Article Order Full text via Infotrieve Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Kasami, M. Articles by Page, D. L. Search for Related Content PubMed PubMed Citation Articles by Kasami, M. Articles by Page, D. L.

American Journal of Pathology, Vol 150, 1925-1932, Copyright © 1997 by American Society for Investigative Pathology

REGULAR ARTICLES

Loss of heterozygosity and microsatellite instability in breast hyperplasia. No obligate correlation of these genetic alterations with subsequent malignancy

M Kasami, CL Vnencak-Jones, S Manning, WD Dupont and DL Page
Division of Anatomic Pathology, Vanderbilt University Medical Center, Nashville, Tennessee 37232, USA.

Loss of heterozygosity and microsatellite instability have been often reported in breast cancer and seldom in proliferative breast disease (PBD). DNA samples from microdissected PBD lesions, including papillomas (25 lesions), from 8 women were analyzed by polymerase chain reaction for loss of heterozygosity and microsatellite instability at 10 loci including INT-2 oncogene locus, D17S796 (the p53 gene region), and D17S579 (in the region of the BRCA-1 gene). In a patient, five loci with microsatellite instability and two loci with loss of heterozygosity were identified in one papilloma with florid hyperplasia and atypia, and 10 other PBD lesions were negative for genetic alteration (GA) and atypia. Three loci with microsatellite instability were identified in another PBD lesion without atypia, whereas another lesion from this second patient had minimal atypia without GAs. These two patients have been well for more than 20 years. No other patient, including a woman developing cancer, had GAs. We detected GAs in PBD (25% of women, 8% of lesions). Incomplete correlation between GAs and anatomic atypia was suggested. It seems evident that several GAs in PBD lesions may not indicate clinically meaningful premalignancy for remaining breast.

This article has been cited by other articles:

				H. Rubin Cell-cell contact interactions conditionally determine suppression and selection of the neoplastic phenotype PNAS, April 29, 2008; 105(17): 6215 - 6221. [Abstract] [Full Text] [PDF]

				Y. Sugita, H. Wada, S. Fujita, T. Nakata, S. Sato, Y. Noguchi, A. A. Jungbluth, M. Yamaguchi, Y.-T. Chen, E. Stockert, et al. NY-ESO-1 Expression and Immunogenicity in Malignant and Benign Breast Tumors Cancer Res., March 15, 2004; 64(6): 2199 - 2204. [Abstract] [Full Text] [PDF]

				N. Franco, L. Arnould, F. Mege, S.-F. Picard, P. Arveux, and S. Lizard-Nacol Comparative Analysis of Molecular Alterations in Fibroadenomas Associated or Not With Breast Cancer Arch Surg, March 1, 2003; 138(3): 291 - 295. [Abstract] [Full Text] [PDF]

				H. Rubin Selected Cell and Selective Microenvironment in Neoplastic Development Cancer Res., February 1, 2001; 61(3): 799 - 807. [Abstract] [Full Text]

				C. Washington, F. Dalbegue, F. Abreo, J. K. Taubenberger, and J. H. Lichy Loss of Heterozygosity in Fibrocystic Change of the Breast : Genetic Relationship Between Benign Proliferative Lesions and Associated Carcinomas Am. J. Pathol., July 1, 2000; 157(1): 323 - 329. [Abstract] [Full Text] [PDF]